Overview
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Eligibility
Inclusion Criteria:
- Aged ≥65 years with newly pathologically confirmed NPC
- Karnofsky performance status ≥60
- Clinical stage III-IVA (Union for International Cancer Control and American Joint Committee on Cancer staging system for NPC, 8th edition)
- Adequate organ function
Exclusion Criteria:
- Cancer history
- Prior radiotherapy, cytotoxic chemotherapy, immunotherapy or target therapy
- Life-expectance within 6 months